<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of <z:chebi fb="1" ids="50694">minocycline</z:chebi> in preventing white matter injury, in particular the injury to developing oligodendrocytes was examined in a neonatal rat model of <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was achieved through bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by exposure to <z:mp ids='MP_0005039'>hypoxia</z:mp> (8% oxygen) for 15 min in postnatal day 4 Sprague-Dawley rats </plain></SENT>
<SENT sid="2" pm="."><plain>A sham operation was performed in control rats </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="1" ids="50694">Minocycline</z:chebi> (45 mg/kg) or <z:mpath ids='MPATH_458'>normal</z:mpath> phosphate-buffered saline was administered intraperitoneally 12 h before and immediately after bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp>+<z:mp ids='MP_0005039'>hypoxia</z:mp> and then every 24 h for 3 days </plain></SENT>
<SENT sid="4" pm="."><plain>Nissl staining revealed pyknotic cells in the white matter area of the rat brain 1 and 5 days after <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> insult also resulted in apoptotic oligodendrocyte cell <z:hpo ids='HP_0011420'>death</z:hpo>, loss of O4+ and O1+ oligodendrocyte immunoreactivity, and <z:hpo ids='HP_0003429'>hypomyelination</z:hpo> as indicated by decreased myelin basic protein immunostaining and by loss of mature oligodendrocytes in the rat brain </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="1" ids="50694">Minocycline</z:chebi> significantly attenuated <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced brain injury </plain></SENT>
<SENT sid="7" pm="."><plain>The protective effect of <z:chebi fb="1" ids="50694">minocycline</z:chebi> was associated with suppression of <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced microglial activation as indicated by the decreased number of activated microglia, which were also interleukin-1beta and inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase expressing cells </plain></SENT>
<SENT sid="8" pm="."><plain>The protective effect of <z:chebi fb="1" ids="50694">minocycline</z:chebi> was also linked with reduction in <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced oxidative and nitrosative stress as indicated by <z:chebi fb="0" ids="32585">4-hydroxynonenal</z:chebi> and nitrotyrosine positive oligodendrocytes, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>The reduction in <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:mp ids='MP_0003674'>oxidative stress</z:mp> was also evidenced by the decreases in the content of <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> in the <z:chebi fb="1" ids="50694">minocycline</z:chebi>-treated <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> rat brain as compared with that in the vehicle-treated <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> rat brain </plain></SENT>
<SENT sid="10" pm="."><plain>The overall results suggest that reduction in microglial activation may protect developing oligodendrocytes in the neonatal brain from <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> injury </plain></SENT>
</text></document>